TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $90,400,000 | -0.3% | 5,518,932 | +2.5% | 0.01% | +12.5% |
| Q2 2021 | $90,651,000 | -8.7% | 5,386,303 | -0.9% | 0.01% | -20.0% |
| Q1 2021 | $99,278,000 | +1.7% | 5,436,898 | +1.4% | 0.01% | 0.0% |
| Q4 2020 | $97,600,000 | +1.6% | 5,362,644 | -0.4% | 0.01% | -9.1% |
| Q3 2020 | $96,043,000 | -2.5% | 5,383,566 | -2.0% | 0.01% | -8.3% |
| Q2 2020 | $98,531,000 | +16.6% | 5,495,336 | -1.3% | 0.01% | -7.7% |
| Q1 2020 | $84,514,000 | +4.2% | 5,567,466 | +35.5% | 0.01% | +18.2% |
| Q4 2019 | $81,078,000 | +13.4% | 4,109,398 | -1.1% | 0.01% | +10.0% |
| Q3 2019 | $71,490,000 | -3.3% | 4,156,367 | -0.5% | 0.01% | 0.0% |
| Q2 2019 | $73,913,000 | -39.1% | 4,175,898 | -29.9% | 0.01% | -44.4% |
| Q1 2019 | $121,336,000 | – | 5,956,597 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |